Ticker >

Kothari Phytochem. share price

Kothari Phytochemicals & Industries Ltd.

SECTOR: Pharmaceuticals & Drugs  1048   0   0

0
0 0

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 0

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

0 Cr.

Enterprise Value

-8.55 Cr.

No. of Shares

0 Cr.

P/E

0

P/B

0

Face Value

₹ 0

Div. Yield

0 %

Book Value (TTM)

₹  -106.26

CASH

8.55 Cr.

DEBT

0 Cr.

Promoter Holding

-

EPS (TTM)

₹  4.86

Sales Growth

-1.45%

ROE

14.09 %

ROCE

18.26%

Profit Growth

-24.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-1.45%
3 Year-3.68%
5 Year4.23%

Profit Growth

1 Year-24.81%
3 Year21.44%
5 Year21.07%

ROE%

1 Year14.09%
3 Year12.42%
5 Year12.71%

ROCE %

1 Year18.26%
3 Year16.83%
5 Year16.97%

Debt/Equity

0

Price to Cash Flow

0

Interest Cover Ratio

304.663743882064

CFO/PAT (5 Yr. Avg.)

0.638561533259562

Shareholding Pattern

Investors List Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 304.663743882064.
  • The Company has been maintaining an effective average operating margins of 22.7497965155402% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 63.5658261742809 days.
  • Company has a healthy liquidity position with current ratio of 15.0053106435622.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 20.8459097404963.

 Limitations

  • The company has shown a poor revenue growth of -3.67536214516951% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 23.95 28.03 21.44 25.42 25.05
Total Expenditure 19.48 22.27 19.69 15.53 18.14
Operating Profit 4.46 5.77 1.75 9.89 6.92
Other Income 6.95 2.46 0.95 7.98 6.51
Interest 0.08 0.06 0.04 0.02 0.04
Depreciation 0.93 0.89 0.75 0.64 0.5
Exceptional Items 0 0 0 0 0
Profit Before Tax 10.4 7.27 1.91 17.21 12.89
Tax 2.65 1.69 1.26 4.02 2.91
Net Profit 7.75 5.59 0.64 13.31 10.01
Adjusted EPS (Rs.) 19.96 14.39 1.66 33.98 25.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 3.88 3.88 3.88 3.88 3.88
Total Reserves 47.92 52.11 49.47 62.78 71.04
Borrowings 0 0 0 0 0
Other N/C liabilities 0.7 0.85 0.47 1.17 1.73
Current liabilities 2.56 3.62 2.06 2.01 1.85
Total Liabilities 55.06 60.46 55.89 69.85 78.51
Assets
Net Block 6.05 5.46 4.88 4.49 4.07
Capital WIP 3.07 3.28 3.42 3.45 3.45
Intangible WIP 0 0 0 0 0
Investments 17.52 28.1 25.58 33.52 42.95
Loans & Advances 0.29 0.25 0.24 0.24 0.24
Other N/C Assets 0.01 0.01 0.01 0.01 0.01
Current Assets 28.13 23.36 21.77 28.14 27.78
Total Assets 55.06 60.46 55.89 69.85 78.51
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 10.4 7.27 1.91 17.21 12.89
Adjustment -5.85 -1.52 3.33 -7.32 -6.01
Changes in Assets & Liabilities 3.1 -1.37 2.99 -2.42 -0.43
Tax Paid -1.88 -1.38 -1.56 -3.24 -2.42
Operating Cash Flow 5.77 3.02 6.67 4.23 4.03
Investing Cash Flow 2.47 -3.79 5.02 -4.5 -8.98
Financing Cash Flow -4.54 -0.18 -4.61 0 -1.75
Net Cash Flow 3.71 -0.95 7.09 -0.26 -6.7

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
 No Investors Data available for this company.
Report us

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

 No Latest News available for this company.
Report us

Kothari Phytochem. Stock Price Analysis and Quick Research Report. Is Kothari Phytochem. an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kothari Phytochem. and its performance over the period of time. Kothari Phytochem. stock price today is Rs 0.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kothari Phytochem. cash from the operating activity was Rs 4.0317243 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kothari Phytochem. has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kothari Phytochem. , the EPS growth was -24.3778552211841 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kothari Phytochem. has OPM of 27.6035272789869 % which is a good sign for profitability.
     
  • ROE: Kothari Phytochem. have a average ROE of 14.0939553769027 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kothari Phytochem. is Rs 0. One can use valuation calculators of ticker to know if Kothari Phytochem. share price is undervalued or overvalued.
Last Updated on:
Brief about Kothari Phytochem.
X